Merck | Omløpsmidler



Current Assets Endring Dato
Adidas EUR 11.9B 762M 2024-12
Adyen EUR 10.89B 1.34B 2024-12
Akzo Nobel EUR 5.84B 1.14B 2024-12
Alcon AG USD 6.31B 10M 2024-12
Amadeus IT EUR 2.59B 16.9M 2024-12
Amarin USD 650.22M 51.62M 2024-09
AstraZeneca USD 25.83B 1.67B 2024-12
BASF EUR 31.72B 2.04B 2024-09
Bayer EUR 34.44B 1.31B 2024-12
Beiersdorf EUR 6.44B 780M 2024-12
Covestro EUR 6.09B 107M 2024-09
Danone EUR 12.79B 512M 2024-12
Fresenius EUR 11.45B 219M 2024-12
Fresenius Medical Care EUR 7.92B 168.26M 2024-12
Galapagos EUR 3.34B 219.98M 2024-12
Genmab DKK 27.85B 4.16B 2024-12
Givaudan CHF 4.24B 629M 2024-06
GlaxoSmithKline GBP 17B 301M 2024-12
GRIFOLS EUR 5.73B 404.28M 2024-12
Henkel EUR 9.74B 458M 2024-06
Hikma Pharmaceutical USD 2.28B 185M 2024-06
Infineon EUR 9.94B 144M 2024-12
Linde USD 12.94B 515M 2024-12
Lonza CHF 5.44B 113M 2024-12
Merck EUR 13.93B 882M 2024-09
Novartis USD 29.7B 1.56B 2024-12
Philips EUR 10.02B 116M 2024-12
Roche Holding CHF 40.04B 6.41B 2024-12
Sanofi 30.08B 589M 2024-06
UCB EUR 4.79B 1.47B 2024-12



Merck Omløpsmidler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.